Gastroenterological Surgery and Management of Clostridioides difficile Infection: A Review

Area of Science:

• Infectious Diseases
• Microbiology
• Gastroenterology

Background:

• Clostridioides difficile infection (CDI) is a significant cause of healthcare-associated infections.
• Spores of C. difficile exhibit resistance to disinfectants, contributing to their persistence in clinical settings.
• Severe CDI manifestations include pseudomembranous enteritis, megacolonization, and paralytic ileus.

Purpose of the Study:

• To review current diagnostic methods for Clostridioides difficile infection.
• To outline risk factors associated with CDI development and persistence.
• To discuss therapeutic approaches and recent advancements in CDI management.

Main Methods:

• Review of diagnostic techniques including glutamate dehydrogenase, toxin assays, and nucleic acid amplification tests (NAAT).
• Identification and analysis of established risk factors for CDI.
• Examination of treatment strategies based on disease severity and recurrence, including novel antimicrobial breakpoints.

Main Results:

• Rapid diagnostic tests offer simplicity, while NAAT provides high specificity for C. difficile toxin detection.
• Key risk factors include advanced age, prior antibiotic use, hospitalization, specific comorbidities, and certain medications like proton pump inhibitors.
• The European Committee on Antimicrobial Susceptibility Testing established a fidaxomicin breakpoint in January 2024.

Conclusions:

• Multidisciplinary collaboration is essential for optimal diagnosis, treatment, and control of CDI.
• Understanding risk factors and utilizing appropriate diagnostic tools are critical for patient management.
• Ongoing research and updated guidelines contribute to improved therapeutic outcomes for CDI.